Partial abdominal evisceration and intestinal autotransplantation to resect a mesenteric carcinoid tumor

Por Kitchens, William H, Elias, Nahel, Blaszkowsky, Lawrence S, Cosimi, A Benedict, Hertl, Martin
Publicado em 2011

Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer

Por Raval, Mihir, Bande, Dinesh, Pillai, Anil K., Blaszkowsky, Lawrence S., Ganguli, Suvranu, Beg, Muhammad S., Kalva, Sanjeeva P.
Publicado em 2014

Transarterial Chemoembolization With Doxorubicin-Eluting Microspheres for Inoperable Hepatocellular Carcinoma

Por Kalva, Sanjeeva P., Iqbal, Shams I., Yeddula, Kalpana, Blaszkowsky, Lawrence S., Akbar, Adnan, Wicky, Stephan, Zhu, Andrew X.
Publicado em 2011

Added Value of Selected Images Embedded Into Radiology Reports to Referring Clinicians

Por Iyer, Veena R., Hahn, Peter F., Blaszkowsky, Lawrence S., Thayer, Sarah P., Halpern, Elkan F., Harisinghani, Mukesh G.
Publicado em 2010

Caring for One of Our Own

Por Schapira, Lidia, Blaszkowsky, Lawrence S., Cashavelly, Barbara J., Kim, Christina Y., Riley, John P., Wold, Mali C., Ryan, David P., Penson, Richard T.
Publicado em 2014

A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors

Por Kulke, Matthew H., Chan, Jennifer A., Meyerhardt, Jeffrey A., Zhu, Andrew X., Abrams, Thomas A., Blaszkowsky, Lawrence S., Regan, Eileen, Sidor, Carolyn, Fuchs, Charles S.
Publicado em 2010

A Prospective, Phase I/II Study of Everolimus and Temozolomide in Patients with Advanced Pancreatic Neuroendocrine Tumor

Por Chan, Jennifer A., Blaszkowsky, Lawrence, Stuart, Keith, Zhu, Andrew X., Allen, Jill, Wadlow, Raymond, Ryan, David P., Meyerhardt, Jeffrey, Gonzalez, Marielle, Regan, Eileen, Zheng, Hui, Kulke, Matthew H.
Publicado no Cancer (2013)

Oral mTOR Inhibitor Everolimus in Patients With Gemcitabine-Refractory Metastatic Pancreatic Cancer

Por Wolpin, Brian M., Hezel, Aram F., Abrams, Thomas, Blaszkowsky, Lawrence S., Meyerhardt, Jeffrey A., Chan, Jennifer A., Enzinger, Peter C., Allen, Brittany, Clark, Jeffrey W., Ryan, David P., Fuchs, Charles S.
Publicado em 2009

Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors

Por Chan, Jennifer A., Stuart, Keith, Earle, Craig C., Clark, Jeffrey W., Bhargava, Pankaj, Miksad, Rebecca, Blaszkowsky, Lawrence, Enzinger, Peter C., Meyerhardt, Jeffrey A., Zheng, Hui, Fuchs, Charles S., Kulke, Matthew H.
Publicado no J Clin Oncol (2012)

A Phase 2 Study of Oral MKC-1 in Patients with Unresectable or Metastatic Pancreatic Cancer

Por Faris, Jason E., Arnott, Jamie, Zheng, Hui, Ryan, David P., Abrams, Thomas A., Blaszkowsky, Lawrence S., Clark, Jeffrey W., Enzinger, Peter C., Hezel, Aram F., Ng, Kimmie, Wolpin, Brian M., Kwak, Eunice L.
Publicado em 2011

Molecular heterogeneity and receptor co-amplification drive resistance to targeted therapy in MET-amplified esophagogastric cancer

Por Kwak, Eunice L., Ahronian, Leanne G., Siravegna, Giulia, Mussolin, Benedetta, Godfrey, Jason T., Clark, Jeffrey W., Blaszkowsky, Lawrence S., Ryan, David P., Lennerz, Jochen K., Iafrate, A. John, Bardelli, Alberto, Hong, Theodore S., Corcoran, Ryan B.
Publicado no Cancer Discov (2015)

Intraductal Papillary Mucinous Adenocarcinoma of the Pancreas: Clinical Outcomes, Prognostic Factors, and the Role of Adjuvant Therapy

Por Alexander, Brian M., Fernandez-del Castillo, Carlos, Ryan, David P., Kachnic, Lisa A., Hezel, Aram F., Niemierko, Andrzej, Willett, Christopher G., Kozak, Kevin R., Blaszkowsky, Lawrence S., Clark, Jeffrey W., Warshaw, Andrew L., Hong, Theodore S.
Publicado em 2011

Panitumumab in Patients with KRAS Wild-Type Colorectal Cancer after Progression on Cetuximab

Por Wadlow, Raymond C., Hezel, Aram F., Abrams, Thomas A., Blaszkowsky, Lawrence S., Fuchs, Charles S., Kulke, Matthew H., Kwak, Eunice L., Meyerhardt, Jeffrey A., Ryan, David P., Szymonifka, Jackie, Wolpin, Brian M., Zhu, Andrew X., Clark, Jeffrey W.
Publicado em 2012

Updated Long-Term Outcomes and Prognostic Factors for Patients With Unresectable Locally Advanced Pancreatic Cancer Treated With Intraoperative Radiotherapy at the Massachusetts Ge...

Por Cai, Sophie, Hong, Theodore S., Goldberg, Saveli I., Castillo, Carlos Fernandez-del, Thayer, Sarah P., Ferrone, Cristina R., Ryan, David P., Blaszkowsky, Lawrence S., Kwak, Eunice L., Willett, Christopher G., Lillemoe, Keith D., Warshaw, Andrew L., Wo, Jennifer Y.
Publicado no Cancer (2013)

Phase I Study of Cetuximab, Irinotecan, and Vandetanib (ZD6474) as Therapy for Patients with Previously Treated Metastastic Colorectal Cancer

Por Meyerhardt, Jeffrey A., Ancukiewicz, Marek, Abrams, Thomas A., Schrag, Deborah, Enzinger, Peter C., Chan, Jennifer A., Kulke, Matthew H., Wolpin, Brian M., Goldstein, Michael, Blaszkowsky, Lawrence, Zhu, Andrew X., Elliott, Meaghan, Regan, Eileen, Jain, Rakesh K., Duda, Dan G.
Publicado em 2012

Phase 1/2 Study of Everolimus in Advanced Hepatocellular Carcinoma

Por Zhu, Andrew X., Abrams, Thomas A., Miksad, Rebecca, Blaszkowsky, Lawrence S., Meyerhardt, Jeffrey A., Zheng, Hui, Muzikansky, Alona, Clark, Jeffrey W., Kwak, Eunice L., Schrag, Deborah, Jors, Kathryn R., Fuchs, Charles S., Iafrate, A. John, Borger, Darrell R., Ryan, David P.
Publicado em 2011

A prospective feasibility study of respiratory gated proton beam therapy for liver tumors

Por Hong, Theodore S., DeLaney, Thomas F., Mamon, Harvey J., Willett, Christopher G., Yeap, Beow Y., Niemierko, Andrzej, Wolfgang, John A., Lu, Hsiao-Ming, Adams, Judith, Weyman, Elizabeth A., Arellano, Ronald S., Blaszkowsky, Lawrence S., Allen, Jill N., Tanabe, Kenneth K., Ryan, David P., Zhu, Andrew X.
Publicado no Pract Radiat Oncol (2013)

Mutational and Clinical Predictors of Pathologic Complete Response in the Treatment of Locally Advanced Rectal Cancer

Por Russo, Andrea L., Ryan, David P., Borger, Darrell R., Wo, Jennifer Y., Szymonifka, Jackie, Liang, Wen-Yih, Kwak, Eunice L., Blaszkowsky, Lawrence S., Clark, Jeffrey W., Allen, Jill N., Zhu, Andrew X., Berger, David L., Cusack, James C., Mamon, Harvey J., Haigis, Kevin M., Hong, Theodore S.
Publicado no J Gastrointest Cancer (2014)

Efficacy, safety, pharmacokinetics and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: A phase II study

Por Zhu, Andrew X., Ancukiewicz, Marek, Supko, Jeffrey G., Sahani, Dushyant V., Blaszkowsky, Lawrence S., Meyerhardt, Jeffrey A., Abrams, Thomas A., McCleary, Nadine Jackson, Bhargava, Pankaj, Muzikansky, Alona, Sheehan, Susan, Regan, Eileen, Vasudev, Eamala, Knowles, Michelle, Fuchs, Charles S., Ryan, David P., Jain, Rakesh K., Duda, Dan G.
Publicado em 2013

Multicenter Phase II Study of Tivozanib (AV-951) and Everolimus (RAD001) for Patients With Refractory, Metastatic Colorectal Cancer

Por Wolpin, Brian M., Ng, Kimmie, Zhu, Andrew X., Abrams, Thomas, Enzinger, Peter C., McCleary, Nadine J., Schrag, Deborah, Kwak, Eunice L., Allen, Jill N., Bhargava, Pankaj, Chan, Jennifer A., Goessling, Wolfram, Blaszkowsky, Lawrence S., Supko, Jeffrey G., Elliot, Meaghan, Sato, Kaori, Regan, Eileen, Meyerhardt, Jeffrey A., Fuchs, Charles S.
Publicado em 2013